BR9813254A - Antìgeno enterococcus e vacinas - Google Patents
Antìgeno enterococcus e vacinasInfo
- Publication number
- BR9813254A BR9813254A BR9813254-7A BR9813254A BR9813254A BR 9813254 A BR9813254 A BR 9813254A BR 9813254 A BR9813254 A BR 9813254A BR 9813254 A BR9813254 A BR 9813254A
- Authority
- BR
- Brazil
- Prior art keywords
- antigen
- carrier
- vaccines
- galactose
- enterococcus antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Patente de Invenção: "ANTìGENO ENTEROCOCCUS EVACINAS". Uma maioria de isolados clínicos de E. faecalis e de E.faecium se encaixa em dois grupos e três grupos, respectivamente.Os antígenos distintos são associados com cada um dos cincogrupos. Os antígenos de Enterococcus são facilmente obtidos decepas de E. faecalis e de E. faecium e podem induzir a produçãode anticorpos protetores. Conseq³entemente, os antígenos sãoúteis para vacinas que protegem contra infecção por isolados deEnterococcus clinicamente significantes (patogênicos). Osantígenos e anticorpos gerados para os antígenos são tambémúteis nos testes diagnósticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/949,757 US6756361B1 (en) | 1997-10-14 | 1997-10-14 | Enterococcus antigens and vaccines |
PCT/US1998/021561 WO1999018996A1 (en) | 1997-10-14 | 1998-10-14 | Enterococcus antigens and vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9813254A true BR9813254A (pt) | 2001-11-20 |
Family
ID=25489514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9813254-7A BR9813254A (pt) | 1997-10-14 | 1998-10-14 | Antìgeno enterococcus e vacinas |
Country Status (14)
Country | Link |
---|---|
US (2) | US6756361B1 (pt) |
EP (3) | EP1028749B1 (pt) |
JP (2) | JP2001519402A (pt) |
AT (1) | ATE397456T1 (pt) |
AU (1) | AU754890B2 (pt) |
BR (1) | BR9813254A (pt) |
CA (1) | CA2306476A1 (pt) |
CY (1) | CY1108307T1 (pt) |
DE (1) | DE69839587D1 (pt) |
DK (1) | DK1028749T3 (pt) |
ES (1) | ES2308818T3 (pt) |
NZ (1) | NZ504501A (pt) |
PT (1) | PT1028749E (pt) |
WO (1) | WO1999018996A1 (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6905670B2 (en) | 1995-03-28 | 2005-06-14 | The General Hospital Corporation | Methods of screening compounds useful for prevention of infection or pathogenicity |
KR100217772B1 (ko) * | 1996-09-03 | 1999-09-01 | 최진호 | 조명기기의 램프 과열방지 장치 및 방법 |
US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
US7078584B2 (en) | 2000-03-17 | 2006-07-18 | The General Hospital Corporation | Salmonella typhimurium-infected Caenorhabditis elegans for identifying inhibitors of infection |
US7112716B2 (en) | 2000-04-06 | 2006-09-26 | The General Hospital Corporation | Methods for screening and identifying host pathogen defense genes |
US6710403B2 (en) | 2002-07-30 | 2004-03-23 | Fairchild Semiconductor Corporation | Dual trench power MOSFET |
EP2327720A1 (en) * | 2003-05-30 | 2011-06-01 | Intercell AG | Enterococcus antigens |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
US20060165716A1 (en) | 2004-07-29 | 2006-07-27 | Telford John L | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
KR20070104590A (ko) * | 2005-01-10 | 2007-10-26 | 나비 바이오파마슈티컬즈 | 스타필로코쿠스 아우레우스 감염을 치료하는 방법 |
US20110223197A1 (en) | 2005-10-18 | 2011-09-15 | Novartis Vaccines And Diagnostics Inc. | Mucosal and Systemic Immunization with Alphavirus Replicon Particles |
JP5215865B2 (ja) | 2005-11-22 | 2013-06-19 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド | ノロウイルス抗原およびサポウイルス抗原 |
AU2007281934B2 (en) | 2006-01-18 | 2012-11-15 | University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
WO2007109810A2 (en) * | 2006-03-23 | 2007-09-27 | Novartis Ag | Methods for the preparation of imidazole-containing compounds |
CA2646891A1 (en) * | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
CA2646539A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Imidazoquinoxaline compounds as immunomodulators |
WO2007141278A2 (en) | 2006-06-06 | 2007-12-13 | Crucell Holland B.V. | Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof |
EP2027155B1 (en) | 2006-06-06 | 2016-01-27 | Crucell Holland B.V. | Human binding molecules having killing activity against staphylococci and uses thereof |
JP5658564B2 (ja) | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
AU2008299376B2 (en) | 2007-09-12 | 2013-02-28 | Glaxosmithkline Biologicals S.A. | GAS57 mutant antigens and GAS57 antibodies |
KR101773114B1 (ko) | 2007-12-21 | 2017-08-30 | 노파르티스 아게 | 스트렙토라이신 o의 돌연변이 형태 |
BRPI0920041A2 (pt) | 2008-10-06 | 2017-06-27 | Univ Chicago | composições e processos relacionados às proteínas eap, emp e/ou adsa bacterianas |
AU2010204139A1 (en) | 2009-01-12 | 2011-08-11 | Novartis Ag | Cna_B domain antigens in vaccines against gram positive bacteria |
BRPI1010307B1 (pt) | 2009-04-03 | 2021-07-27 | University Of Chicago | Polipeptídeos variantes de proteína a (spa), composição imunogênica compreendendo os mesmos, vacina, método de produção da referida vacina, bem como uso dos referidos polipeptídeos |
ES2596653T3 (es) | 2009-06-16 | 2017-01-11 | Glaxosmithkline Biologicals Sa | Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento |
US10266585B2 (en) | 2009-08-28 | 2019-04-23 | The Board Of Regents Of The Univerity Of Texas System | Methods of treating brain injury |
RU2559543C2 (ru) * | 2010-01-19 | 2015-08-10 | Универзитетсклиникум Фрайбург | Компоненты энтерококковых клеточных стенок и их антибактериальные применения |
JP2013523818A (ja) | 2010-04-05 | 2013-06-17 | ザ・ユニバーシティー・オブ・シカゴ | 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法 |
WO2011149564A1 (en) | 2010-05-28 | 2011-12-01 | Tetris Online, Inc. | Interactive hybrid asynchronous computer game infrastructure |
ES2655701T3 (es) | 2010-07-02 | 2018-02-21 | The University Of Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SpA) |
US9095540B2 (en) | 2010-09-09 | 2015-08-04 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens |
CA2817973C (en) | 2010-10-15 | 2019-06-25 | The Board Of Regents Of The University Of Texas System | Antibodies that bind amyloid oligomers |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
DK2526951T3 (en) * | 2011-05-27 | 2016-01-04 | Universitätsklinikum Freiburg | Rhamnopolysaccharid from Enterococcus faecium clone 17 complex and uses thereof |
CN103906535B (zh) | 2011-08-15 | 2017-07-14 | 芝加哥大学 | 与葡萄球菌蛋白a的抗体相关的组合物和方法 |
CN104768572B (zh) | 2012-04-26 | 2021-08-24 | 芝加哥大学 | 葡萄球菌凝固酶抗原及其使用方法 |
EP2841101B1 (en) | 2012-04-26 | 2019-08-07 | University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
WO2014013375A1 (en) | 2012-07-16 | 2014-01-23 | Pfizer Inc. | Saccharides and uses thereof |
US10125373B2 (en) | 2013-01-22 | 2018-11-13 | Arizona Board Of Regents On Behalf Of Arizona State University | Geminiviral vector for expression of rituximab |
EP3415160B1 (en) * | 2014-03-04 | 2021-08-18 | Klinikum der Universität München | Polypeptides derived from enterococcus and their use for vaccination and the generation of therapeutic antibodies |
WO2017173398A1 (en) | 2016-04-01 | 2017-10-05 | Duke University | Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform |
WO2019183500A1 (en) | 2018-03-23 | 2019-09-26 | Hung Chiung Yu | Coccidioides antigens and methods of their use |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2466251B1 (fr) * | 1979-10-03 | 1983-03-18 | Agronomique Inst Nat Rech | Vaccin animal anticolibacillaire, obtention et application |
US4439422A (en) | 1980-01-02 | 1984-03-27 | Research Corporation | Group B Streptococcus antigens and vaccines |
US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
JPS5927833A (ja) * | 1982-08-06 | 1984-02-14 | Advance Res & Dev Co Ltd | コレステロール乃至トリグリセリド低下剤 |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
FR2546756B1 (fr) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux derives immunostimulants, leur preparation et leur application comme medicament |
US4761283A (en) * | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
JPS6028401A (ja) | 1983-07-27 | 1985-02-13 | Advance Res & Dev Co Ltd | トリグリセリド低下活性多糖類 |
US4626502A (en) * | 1984-01-27 | 1986-12-02 | Abbott Laboratories | Method for exposing bacterial antigen in bacterial cells assay using same |
US4695624A (en) | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
GB8414273D0 (en) * | 1984-06-05 | 1984-07-11 | Oxoid Ltd | Identifying streptococcal grouping |
JPS615022A (ja) * | 1984-06-19 | 1986-01-10 | Advance Res & Dev Co Ltd | 腸内細菌叢改善剤 |
GB8517895D0 (en) * | 1985-07-16 | 1985-08-21 | Technology Licence Co Ltd | Monoclonal antibodies |
US4695524A (en) * | 1986-05-21 | 1987-09-22 | Xerox Corporation | Process for ultra high quality images with magnetic developer composition |
US5143845A (en) * | 1986-09-03 | 1992-09-01 | Toa Pharmaceutical Co., Ltd. | Mixture of saccarifying lactic acid producing and butyric acid producing bacteria |
EP0285649A4 (en) * | 1986-10-08 | 1990-06-27 | David Bernstein | METHOD FOR EXPOSING ANTIGENS OF GROUP A STREPTOCOCCUS AND IMPROVED DIAGNOSTIC TEST FOR THE IDENTIFICATION OF GROUP A STREPTOCOCCUS |
US5032505A (en) | 1988-11-21 | 1991-07-16 | Chembiomed, Ltd. | Inhibitors for glycosaminosyl transferase V |
US5175279A (en) * | 1989-01-19 | 1992-12-29 | Hakuto Co., Ltd. | Polysaccharide, and water absorbent, moisture absorbent or humectant and thickening agent chiefly made of the polysaccharide |
US5032401A (en) * | 1989-06-15 | 1991-07-16 | Alpha Beta Technology | Glucan drug delivery system and adjuvant |
US5010062A (en) * | 1989-09-25 | 1991-04-23 | Vanderbilt University | Therapeutic agent and method of inhibiting vascularization of tumors |
CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
US5858728A (en) * | 1991-03-13 | 1999-01-12 | Common Services Agency | Monoclonal antibody against LPS core |
US5225331A (en) * | 1991-04-25 | 1993-07-06 | National Research Council Of Canada | Immunoassay for detecting group b streptococcus |
US5205917A (en) * | 1991-05-07 | 1993-04-27 | Glyko, Inc. | Fluorophore assisted carbohydrate electrophoresis diagnosis |
ATE232730T1 (de) * | 1991-08-23 | 2003-03-15 | Alberta Res Council | Verfahren und zusammensetzungen zur verhinderung der antikörper-vermittelten abstossung von xenogenen transplantaten |
US5478557A (en) * | 1992-07-29 | 1995-12-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Probiotic for control of salmonella |
RU2101029C1 (ru) * | 1992-11-26 | 1998-01-10 | Товарищество с ограниченной ответственностью "ХИМЭК" | Способ получения препарата для идентификации стрептококка группы д |
GB9310468D0 (en) * | 1993-05-20 | 1993-07-07 | Oxford Glycosystems Ltd | Sugar complexes |
US5367058A (en) * | 1993-08-25 | 1994-11-22 | Becton, Dickinson And Company | Modified antibodies with increased affinity |
JPH0782158A (ja) * | 1993-09-16 | 1995-03-28 | Yakult Honsha Co Ltd | 抗腫瘍剤 |
JP2717497B2 (ja) * | 1993-12-28 | 1998-02-18 | 不二ラテックス株式会社 | 酸性多糖類被覆コンドーム |
GB9401689D0 (en) * | 1994-01-28 | 1994-03-23 | Univ Manchester | Diagnosis and treatment of endocarditis |
US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
US5489302A (en) * | 1994-05-24 | 1996-02-06 | Skottun; Bernt C. | Accommodating intraocular lens |
JPH0827010A (ja) * | 1994-07-19 | 1996-01-30 | Nichinichi Seiyaku Kk | 制癌免疫療法剤 |
US5700787A (en) * | 1994-09-02 | 1997-12-23 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
US5871751A (en) * | 1994-10-12 | 1999-02-16 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Renibacterium salmoninarum vaccine and method for its preparation |
US5569366A (en) * | 1995-01-27 | 1996-10-29 | Beckman Instruments, Inc. | Fluorescent labelled carbohydrates and their analysis |
US5760213A (en) * | 1995-06-05 | 1998-06-02 | Tayca Corporation | Immunoactivating agent |
US5695768A (en) * | 1995-06-07 | 1997-12-09 | Alberta Research Council | Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides |
DE19524515A1 (de) * | 1995-07-05 | 1997-01-09 | Deutsches Krebsforsch | Saccharid-Konjugate |
US6722062B2 (en) * | 1997-08-20 | 2004-04-20 | The Brigham And Women's Hospital, Inc. | Capsular polysaccharides from enterococci |
WO1999008705A1 (en) * | 1997-08-20 | 1999-02-25 | Brigham And Women's Hospital | Capsular polysaccharides from enterococci |
US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
US7030101B2 (en) * | 1998-09-14 | 2006-04-18 | Nabi Biopharmaceuticals | Compositions of β-glucans and specific antibodies |
WO2000015238A1 (en) * | 1998-09-14 | 2000-03-23 | Nabi | COMPOSITIONS OF β-GLUCANS AND SPECIFIC IGIV |
TR200103231T2 (tr) * | 1999-03-12 | 2002-03-21 | University Of Massachusetts | Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì |
US6720160B2 (en) * | 2001-10-11 | 2004-04-13 | Helica Biosystems, Inc. | Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
-
1997
- 1997-10-14 US US08/949,757 patent/US6756361B1/en not_active Expired - Fee Related
-
1998
- 1998-10-14 ES ES98951058T patent/ES2308818T3/es not_active Expired - Lifetime
- 1998-10-14 CA CA002306476A patent/CA2306476A1/en not_active Abandoned
- 1998-10-14 BR BR9813254-7A patent/BR9813254A/pt not_active IP Right Cessation
- 1998-10-14 DE DE69839587T patent/DE69839587D1/de not_active Expired - Lifetime
- 1998-10-14 AU AU96949/98A patent/AU754890B2/en not_active Ceased
- 1998-10-14 JP JP2000515628A patent/JP2001519402A/ja active Pending
- 1998-10-14 DK DK98951058T patent/DK1028749T3/da active
- 1998-10-14 AT AT98951058T patent/ATE397456T1/de active
- 1998-10-14 NZ NZ504501A patent/NZ504501A/en not_active IP Right Cessation
- 1998-10-14 EP EP98951058A patent/EP1028749B1/en not_active Expired - Lifetime
- 1998-10-14 EP EP08008590A patent/EP1970073A1/en not_active Withdrawn
- 1998-10-14 WO PCT/US1998/021561 patent/WO1999018996A1/en active IP Right Grant
- 1998-10-14 PT PT98951058T patent/PT1028749E/pt unknown
- 1998-10-14 EP EP10178313A patent/EP2269635A1/en not_active Withdrawn
-
2004
- 2004-06-28 US US10/876,758 patent/US7291343B2/en not_active Expired - Fee Related
-
2008
- 2008-09-02 CY CY20081100934T patent/CY1108307T1/el unknown
-
2009
- 2009-05-18 JP JP2009119505A patent/JP2009227680A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK1028749T3 (da) | 2008-09-01 |
DE69839587D1 (de) | 2008-07-17 |
US7291343B2 (en) | 2007-11-06 |
ATE397456T1 (de) | 2008-06-15 |
JP2001519402A (ja) | 2001-10-23 |
PT1028749E (pt) | 2008-09-04 |
EP1028749B1 (en) | 2008-06-04 |
JP2009227680A (ja) | 2009-10-08 |
WO1999018996B1 (en) | 1999-06-03 |
US20050008658A1 (en) | 2005-01-13 |
EP1028749A4 (en) | 2003-03-12 |
US6756361B1 (en) | 2004-06-29 |
WO1999018996A1 (en) | 1999-04-22 |
AU754890B2 (en) | 2002-11-28 |
CY1108307T1 (el) | 2014-02-12 |
ES2308818T3 (es) | 2008-12-01 |
NZ504501A (en) | 2003-09-26 |
EP1970073A1 (en) | 2008-09-17 |
EP1028749A1 (en) | 2000-08-23 |
EP2269635A1 (en) | 2011-01-05 |
AU9694998A (en) | 1999-05-03 |
CA2306476A1 (en) | 1999-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9813254A (pt) | Antìgeno enterococcus e vacinas | |
WO1998058668A3 (en) | Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae | |
IL102687A (en) | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them | |
AU8316701A (en) | Anti-dual integrin antibodies, compositions, methods and uses | |
DE122010000015I1 (de) | Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten | |
EP0866133A3 (en) | A group b streptococcus vaccine | |
FI903292A0 (fi) | T-cellepitop som baerarmolekyler foer konjugerade vacciner. | |
ATE237687T1 (de) | Rekombinierte sequenzen des monoklonalen anti- idiotypischen antikörpers 3h1, diean dem menschlichen karzioembyonischen antigen liiert sind | |
AU628948B2 (en) | Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof | |
DK0473721T3 (da) | Antiidiotypisk antistof, som fremkalder en immunreaktion med et glycosphingolipid, og anvendelse deraf | |
WO2001079259A8 (en) | Javelinization of protein antigens to heat shock proteins | |
EP2057999A3 (en) | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines | |
IL109445A0 (en) | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof | |
ATE530572T1 (de) | Antigen-cocktails, p35 und verwendungen dafür | |
EP0153871A3 (en) | Antibody enhancement of immunogenicity of antigen | |
AU4803785A (en) | Cross-reactive and protective epitopes of circumsporozoite proteins | |
DK101196A (da) | Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet | |
CA2333598A1 (en) | Toxoplasma gondii antigens, p35, and uses thereof | |
EP0485476A4 (en) | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof | |
AU622548B2 (en) | Novel tumor-associated antigen, antibodies, compositions and uses therefor | |
GB2267148B (en) | Footrot antigens,vaccines and diagnostic assays | |
AU1626492A (en) | Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof | |
FR2775189B1 (fr) | Compositions anti-tumorales a base d'antigenes hla-g ou d'anticorps anti-hla-g | |
MX9704225A (es) | Fragmentos de anticuerpos monoclonales que tienen actividad inmunosupresora. | |
MX9707295A (es) | Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved | ||
B25K | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Owner name: NABI BIOPHARMACEUTICALS (US) Free format text: REFERENTE A RPI 1793 DE 17/05/2005, COD. DE DESPACHO 25.4, QUANTO AO NOME DO TITULAR. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS ANUIDADES EM DEBITO. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2316 DE 26-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |